about
Probiotics for non-alcoholic fatty liver disease and/or steatohepatitisNon-alcoholic fatty liver disease: what the clinician needs to know.Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersA systematic review of the diagnostic accuracy of physical examination for the detection of cirrhosis.The Natural Course of Non-Alcoholic Fatty Liver DiseaseNAFLD and Chronic Kidney DiseaseDietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayComposite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesNon-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Fructose as a key player in the development of fatty liver diseaseLiver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis CSTEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver diseaseEvaluation of liver fibrosis: "Something old, something new…"A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease.Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityPerformance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataGATA binding protein 3 is correlated with leptin regulation of PPARγ1 in hepatic stellate cellsWhat are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean PopulationLiver fibrosis markers of nonalcoholic steatohepatitis.Detecting hepatic steatosis using ultrasound-induced thermal strain imaging: an ex vivo animal study.Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease.Can NASH be diagnosed, graded, and staged noninvasively?Inflammation in nonalcoholic steatohepatitis.Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease populationShear wave velocity is a useful marker for managing nonalcoholic steatohepatitisDiagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver diseaseMetabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?Nonalcoholic fatty liver disease: Diagnostic biomarkers.Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis.Cryptogenic cirrhosis in the region where obesity is not prevalent.Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians.Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.
P2860
Q24243033-A69C6001-2360-4638-BCB1-49A48E5D36FBQ24563068-76F43ED7-25B4-4653-A766-278C0E159FF3Q24644869-F144FA81-93C3-431D-B3B9-C579A98486B5Q24798519-8F2DDDBE-2F4A-4767-98F9-46CBEEBF08E8Q26746947-EDDA7D31-A329-41E0-B8E5-E0C8091B9C5FQ26752759-04A17C4A-36EC-4F3D-A19E-887986B88B8DQ26777658-FE7FA6CB-E1E3-44F1-8ADF-31EE7144606AQ26800894-FD450F4A-C8B1-4D0F-9367-A22F57ECF9D5Q26828855-49D96951-DACA-4E4B-A159-859D3AF9BA8CQ26829503-A7BBDDF7-08E3-41EE-A7DF-6AF4BFCFC42FQ27014596-D9E7F066-5599-4ABF-93B5-45D34B2E97F2Q27477966-A52C0E4C-3AD8-4826-B3D1-01510321A288Q27478329-10829981-A555-463E-A077-A93688C71363Q27496667-46404392-4750-4027-B2E3-B248DBA75C34Q28068532-D87CCDD8-DB41-4839-8F1E-708B4878D153Q28074377-59F55859-0D0A-440A-AB70-24C0284C77E4Q28297290-9DEF72EA-8611-4C1E-85E2-E18D4F1A61F1Q28481485-97872174-29E1-4008-B34F-C77CD87239B8Q29048609-FAE9CA67-4A0B-4F15-865E-2CBFEC501D98Q30361645-6B3ACEF4-A864-4056-86E4-215A069FA846Q30377409-914E7042-6E67-4653-A43D-2C170BAA2729Q30382278-1A28ADEE-CDE4-42AB-8BDF-9E7EFDBE684EQ30393424-C04372B5-50F7-4C09-AA58-1CAEDA1CE636Q30407625-55E134FD-AE1B-453B-BE79-0500D671BEEFQ30418371-E5339EB8-9F01-4A9E-8258-EDAA0B616EE6Q30432576-E5BEF05C-B8F8-47CD-B1EA-DA3922EF43C8Q30433234-D026FA97-DBE2-4695-876E-D49DA0D832C4Q30451362-8A02986C-BE2E-4F30-977B-3048EF87A547Q30453231-D57E8A98-83C7-434D-9B94-348D189A76EDQ30471258-91C5F21D-C95D-4132-87BD-31AB0F2DC658Q30480973-F6CE5D14-E770-454B-AF77-9B32401C0524Q33263279-9966E338-D18B-4827-86A6-EF94DD1A20D7Q33384921-C9115790-2A39-4A9E-82BC-6F50BA49CFDCQ33437876-B236BFC9-BCE2-4381-8D46-764EA9D018ACQ33660027-CB7C92E4-F120-4FDE-A6CA-E4862C8F3087Q33706254-F5EB8F11-6C22-4666-A0AC-2763C2597177Q33866722-6B25F9FF-88CB-411A-A4F4-9754576D5B89Q33867312-05B80383-7924-4E5A-A3C4-0FDEA66B73FDQ33867976-7948CDBF-1068-4F6E-A1FA-FEE6D89859D2Q33937093-13EE773B-2C84-4759-B5AF-E9F8C08D3EDB
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Liver fibrosis in overweight patients
@ast
Liver fibrosis in overweight patients
@en
Liver fibrosis in overweight patients
@nl
type
label
Liver fibrosis in overweight patients
@ast
Liver fibrosis in overweight patients
@en
Liver fibrosis in overweight patients
@nl
prefLabel
Liver fibrosis in overweight patients
@ast
Liver fibrosis in overweight patients
@en
Liver fibrosis in overweight patients
@nl
P2093
P3181
P1433
P1476
Liver fibrosis in overweight patients
@en
P2093
E Bruckert
F Charlotte
I Theodorou
V Thibault
P304
P3181
P356
10.1016/S0016-5085(00)70364-7
P407
P577
2000-06-01T00:00:00Z